Using Silverlon® for Head and Neck Patients With Tracheostomies

Part of paid clinical trials in Syracuse, New York.

Sponsor
State University of New York - Upstate Medical University
Study ID
NCT07856732
Phase
PHASE1
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Silverlon® — DEVICE
    Silverlon® is a specialized, antimicrobial wound dressings that is approved in radiation dermatitis. The study is aimed at determining if this dressing is effective in prophylactically preventing dermatitis in high risk patients.

Study Details

The purpose of this study is to determine if prophylactic silver-nylon burn dressing Silverlon® prevents a severe skin reaction under tracheostomy collars. It also aims to establish whether patients can tolerate Silverlon® under their tracheostomy with daily removal and weekly changes.

Key Dates

First listed
Oct 5, 2026
Start date
Aug 30, 2026
Status verified
Aug 2026
Primary completion
Aug 30, 2027
Completion
Jan 30, 2028

Study Design

Enrollment
10 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION

Arms

  • Experimental: Using Silverlon®
    Patients will be given Silverlon®

Primary Outcome Measure

Feasibility of Silveron dressing [ Time Frame: 7 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Upstate Medical UniversitySyracuseNew York12310
Karna Sura, MD
[email protected]
315-464-5276

Find similar trials in Syracuse, NY

Nationwide
Head and neck cancer trialsOncology trialsENT trials
By condition
Head and neck cancer
By specialty
OncologyENT
By research site
Upstate Medical University· Syracuse, NY

Related Studies